FLEMINGTON, N.J.--(BUSINESS WIRE)--NovaDel Pharma Inc. (AMEX: NVD), a novel drug delivery and specialty pharmaceutical company, today announced that NovaDel’s President and Chief Executive Officer, Dr. Jan Egberts, is scheduled to provide a corporate update at the upcoming Bio CEO & Investor Conference in New York City. Details for this event are as follows:
